Healthcare - Biotechnology - NASDAQ - US
$ 9.905
-11.1 %
$ 618 M
Market Cap
-1.31
P/E
Price Target
Average
206.24%
Revenue Forecast
Estimate
100.08%
EBIT
Estimate
34.07%
Net Income
Estimate
38.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immunome, Inc.
Wall Street analysts predict an average 1-year price target for IMNM of $30.3 , with forecasts ranging from a low of $23 to a high of $35 .
IMNM Lowest Price Target
Wall Street Target
23 USD
132.21%
IMNM Average Price Target
Wall Street Target
30.3 USD
206.24%
IMNM Highest Price Target
Wall Street Target
35 USD
253.36%
REVENUE FORECAST
Revenue Forecast Chart IMNM
EBIT FORECAST
EBIT Forecast Chart IMNM
NET INCOME FORECAST
Net Income Chart IMNM